A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia
Clinical trial NCT01606228 · COMPLETED
Trial details
- NCT number
- NCT01606228
- Sponsor
- Janssen Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-12-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.